To Pay or Not to Pay: Medicare’s Big Aduhelm Decision
In June, the FDA approved aducanumab (Aduhelm) to treat patients with Alzheimer’s disease using the agency’s accelerated approval pathway, despite significant concerns about the evidence regarding the drug’s safety and effectiveness. The agency’s approval decision contradicted the recommendations of its own advisory committee, which voted overwhelmingly against the evidence presented in support of the drug. […]
Phone Calls Spot Early Alzheimer’s
Speech patterns in phone conversations can spot people with early to moderate Alzheimer’s dementia, a Japanese study suggested. A machine-learning predictive model correctly identified people with Alzheimer’s dementia with about 90% accuracy using audio files of phone conversations of 24 people with confirmed Alzheimer’s and 99 healthy controls, reported Akihiro Shimoda, MPH, of McCann Health […]
Alzheimer’s Aducanumab Prescribing Information Changes
Just a month after it gave the new Alzheimer’s drug aducanumab (Aduhelm) the green light, the FDA decided to change the label. The agency approved an updated label narrowing who should receive the drug, stating that aducanumab should be initiated in Alzheimer’s patients with “mild cognitive impairment or mild dementia stage of disease, the population […]
Healthy Living Reduces Alzheimer’s Risk – MedicineNet Health News
Latest Alzheimer’s News TUESDAY, June 29, 2021 Alzheimer’s disease has no cure, but one expert says it may be possible to reduce the risks of developing the disease with healthy lifestyle changes. There are two different types of Alzheimer’s. Early-onset typically affects patients before age 65. Late-onset affects older adults. “Early-onset dementia often […]